Objective To evaluate the physical and neuropsychological development of children with dietation-treated phenylketonuria (PKU). Methods A total of 41 PKU children with phenylalanine hydroxylase deficiency in Wuxi city from January 2004 to December 2014 were enrolled. Height (length),weight and neuropsychological development scale for children aged 0-6 years were monitored,and phenylalanine dietary control index was calculated. Results 1)The blood phenylalanine concentration of PKU children decreased significantly before and after treatment,with an average decrease(506.57±40.54) μmol/L,which was statistical significance (H=21.232, P<0.05).2)Among children aged 6 months,1 year,2 years and 3 years,the medium level height and weight accounted for the most,the height accounted for 70.7%,65.9%,68.3% and 68.3%,respectively,and the medium weight accounted for 78.0%,73.2%,75.6% and 73.2%,respectively.3)There were no significant differences on the physical and neuropsychological between children of different ages and types of PKU(P>0.05).4)The level of neuropsychological development was negatively correlated with the diagnosis and treatment time,blood phenylalanine concentration and dietary control index of PKU children (r=-0.601,-0.838,-0.792,P <0.05). Conclusion PKU children treated with diet and standardized follow-up can maintain normal physical and neuropsychological development levels,which are affected by the time of diagnosis and treatment and the concentration of phenylalanine in blood.
Key words
phenylketonuria /
dietary therapy /
neuropsychological development /
children
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 中华医学会儿科学分会内分泌遗传代谢学组,中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组,高苯丙氨酸血症的诊治共识[J].中华儿科杂志,2014,52(6):420-425.
[2] 叶军,顾学范.高苯丙氨酸血症诊治共识解读[J].中华儿科杂志,2014,52(6):430-432.
[3] 陈挺,赵正言,蒋萍萍,等.高苯丙氨酸血症表型与基因型研究进展[J].浙江大学学报:医学版,2018,47(3):219-226.
[4] Singh RH,Rohr F,Frazier D,et al.Recommendations for the nutrition management of phenylalanine bydroxylase deficiency[J].Genet Med,2014,16(2):121-131.
[5] 中华人民共和国卫生部.苯丙酮尿症和先天性甲状腺功能减低症诊治技术规范[卫妇社发(96)号][S].2011.
[6] 朱玲,杨建平,董勤,等.97例苯丙酮尿症患儿的治疗效果[J].中华围产医学杂志,2015,18(3):200-203.
[7] Rohde C,von Teeffelen-Heithoff A,Thiele AG,et al.PKU patients on a relaxed diet may be at risk for micronutrient deficiencies[J].Eur J Clin Nutr,2014,68(1):119-124.
[8] van Wegberg AMJ,MacDonald A,Ahring K,et al.The complete European guidelines on phenylketonuria:diagnosis and treatment[J].Orphanet J Rare Dis,2017,12(1):162.
[9] 毛新梅,田海燕,马晓燕.宁夏106例苯丙酮尿症患儿低苯丙氨酸饮食控制疗效评估[J].宁夏医科大学学报,2016,38(8):897-900.
[10] 李松,孙巧玲,周怡,等.安徽省174例苯丙酮尿症患儿智力发育及其影响因素分析[J].中华疾病控制杂志,2015,19(5):466-469.
[11] van Spronsen FJ,van Wegberg AM,Ahring K,et al.Key Eu ropean guidelines for the diagnosis and management of patients with phenylketonuria[J].Lancet Diabetes Endo,2017,5(9):743-756.
[12] Jahja R,Huijbregts SC,de Sonneville LM,et al.Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria[J].J Pediatr,2014,164(4):895-899.